Rice Hall James & Associates’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-93,081
| Closed | -$3.82M | – | 263 |
|
|
2024
Q2 | $3.82M | Buy |
93,081
+3,355
| +4% | +$138K | 0.23% | 99 |
|
|
2024
Q1 | $3.89M | Buy |
89,726
+121
| +0.1% | +$5.24K | 0.22% | 94 |
|
|
2023
Q4 | $4.12M | Sell |
89,605
-67,821
| -43% | -$3.12M | 0.24% | 96 |
|
|
2023
Q3 | $3.61M | Sell |
157,426
-1,533
| -1% | -$35.1K | 0.23% | 103 |
|
|
2023
Q2 | $2.62M | Buy |
158,959
+5,173
| +3% | +$85.3K | 0.15% | 149 |
|
|
2023
Q1 | $2.74M | Buy |
153,786
+584
| +0.4% | +$10.4K | 0.16% | 153 |
|
|
2022
Q4 | $4.46M | Sell |
153,202
-17,155
| -10% | -$500K | 0.26% | 93 |
|
|
2022
Q3 | $4.17M | Buy |
170,357
+11,357
| +7% | +$278K | 0.24% | 102 |
|
|
2022
Q2 | $660K | Buy |
159,000
+22,479
| +16% | +$93.3K | 0.03% | 238 |
|
|
2022
Q1 | $1.57M | Buy |
136,521
+8,975
| +7% | +$103K | 0.06% | 225 |
|
|
2021
Q4 | $1.27M | Sell |
127,546
-22,174
| -15% | -$221K | 0.05% | 235 |
|
|
2021
Q3 | $1.96M | Buy |
149,720
+5,726
| +4% | +$74.8K | 0.07% | 208 |
|
|
2021
Q2 | $2.82M | Buy |
143,994
+79,733
| +124% | +$1.56M | 0.1% | 160 |
|
|
2021
Q1 | $1.37M | Buy |
64,261
+15,538
| +32% | +$331K | 0.04% | 239 |
|
|
2020
Q4 | $1.45M | Sell |
48,723
-5,868
| -11% | -$175K | 0.05% | 228 |
|
|
2020
Q3 | $1.18M | Buy |
54,591
+17,381
| +47% | +$377K | 0.05% | 223 |
|
|
2020
Q2 | $830K | Sell |
37,210
-24,704
| -40% | -$551K | 0.04% | 220 |
|
|
2020
Q1 | $942K | Buy |
61,914
+619
| +1% | +$9.42K | 0.05% | 202 |
|
|
2019
Q4 | $1.41M | Sell |
61,295
-3,509
| -5% | -$80.5K | 0.05% | 209 |
|
|
2019
Q3 | $1.4M | Buy |
64,804
+1,587
| +3% | +$34.3K | 0.05% | 211 |
|
|
2019
Q2 | $1.39M | Buy |
63,217
+40,015
| +172% | +$880K | 0.05% | 221 |
|
|
2019
Q1 | $636K | Buy |
+23,202
| New | +$636K | 0.02% | 262 |
|